What is the name of the act that requires pharma companies in the US to report payments over $10 to physicians?

The Sunshine Act is significant because it mandates transparency regarding financial relationships between the pharmaceutical industry and healthcare providers. Under this act, pharmaceutical companies are required to report any payments or transfers of value exceeding $10 to physicians and teaching hospitals. This requirement aims to promote accountability and transparency, allowing the public to understand potential conflicts of interest that may arise from the financial ties between these two sectors.

The other acts mentioned do not serve this purpose. The Health Insurance Portability and Accountability Act primarily focuses on the protection of patient information and privacy. The Federal Food, Drug, and Cosmetic Act regulates the safety and efficacy of drugs and devices but does not pertain to financial disclosures. The False Claims Act addresses fraudulent claims made to the government but does not have a specific requirement for the reporting of payments to healthcare professionals. This reinforces why the Sunshine Act is the act that directly addresses the need for reporting these financial relationships.